Skip to main content
Clinical Trials/NCT04674995
NCT04674995
Completed
Not Applicable

Stent Versus Balloon Dilatation in Patients With Tracheal Benign Stenosis

University of Modena and Reggio Emilia0 sites66 target enrollmentNovember 1, 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tracheal Stenosis
Sponsor
University of Modena and Reggio Emilia
Enrollment
66
Primary Endpoint
Re-stenosis rate over time
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This is a retrospective, observational cohort study carried out in two operative Units of the University Hospital of Modena (Italy): the Diagnostic and Interventional Bronchoscopy Unit (Unit A) and the Otolaryngology Unit (Unit B). The two units have different protocols routinely applied to treat tracheal benign stenosis. In Unit A, endoscopic treatment is performed through mechanical dilatation via rigid bronchoscopy and further stent placing while in Unit B the endoscopic treatment is performed through balloon dilatation via direct laryngoscopy. The primary purpose was to compare the efficacy of the two technique on tracheal stenosis treatment over time. Patients were defined as "cured" if during the 2 years after 12 months since the last intervention they did not present any of the following: respiratory symptoms, need for a re-intervention or stenosis instability.

Registry
clinicaltrials.gov
Start Date
November 1, 2012
End Date
December 1, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Modena and Reggio Emilia
Responsible Party
Principal Investigator
Principal Investigator

Alessandro Marchioni

Principal Investigator

University of Modena and Reggio Emilia

Eligibility Criteria

Inclusion Criteria

  • age \>18 years,
  • exclusion from resection-anastomosis surgery after multidisciplinary evaluation,
  • Cotton Meyer \> grade II,
  • follow-up of at least 3 years after endoscopic surgery,
  • no previous tracheal surgery.

Exclusion Criteria

  • age \> 80,
  • stent intolerance which requires removal in the first year after endoscopic treatment,
  • performance status \> 2,
  • end-stage chronic pulmonary disease,
  • life-threatening stenosis that needs urgent endoscopic treatments,
  • any neoplastic stenosis of the airways,
  • dynamic etiology of tracheal benign stenosis (excessive dynamic airway collapse, tracheobronchomalacia).

Outcomes

Primary Outcomes

Re-stenosis rate over time

Time Frame: 36 months

Patients were defined as cured if during the 2 years after 12 months since the last intervention they did not present any of the following: respiratory symptoms, need for a re-intervention or stenosis instability.

Similar Trials